Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

RCVS should be considered in thunderclap headaches, and MRA and DSA are better for diagnosis than CT angiogram.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

The drug combination significantly reduced epileptic drop attacks in patients.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Higher doses of glucocorticoids increase the risk of blood clots in asthma patients.

Strontium ranelate is no longer available for treatment.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Cedrol may be an effective treatment for colorectal cancer.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.